|
|
Volumn 16, Issue 3, 2007, Pages 132-134
|
|
New ESH/ESC Guidelines signal progress in hypertension management
a a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANGIOTENSIN RECEPTOR ANTAGONIST;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
THIAZIDE DIURETIC AGENT;
BLOOD PRESSURE MONITORING;
BLOOD PRESSURE REGULATION;
CARDIOVASCULAR RISK;
CLINICAL PROTOCOL;
DIABETES MELLITUS;
DIABETIC NEUROPATHY;
DISEASE MARKER;
EDITORIAL;
HIGH RISK PATIENT;
HUMAN;
HYPERTENSION;
LIFESTYLE MODIFICATION;
MEDICAL SOCIETY;
METABOLIC SYNDROME X;
MICROALBUMINURIA;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
RISK ASSESSMENT;
CARDIOVASCULAR DISEASES;
EUROPE;
HUMANS;
HYPERTENSION;
PRACTICE GUIDELINES;
RISK FACTORS;
|
|
EID: 34548650032
PISSN: 08037051
EISSN: 16511999
Source Type: Journal
DOI: 10.1080/08037050701550746 Document Type: Editorial |
|
Times cited : (3)
|
|
References (1)
|
